Line 300: |
Line 300: |
| | | | | |
| |- | | |- |
− | |Acute Undifferentiated Leukemia||Disease|| ||JH | + | | Acute Undifferentiated Leukemia||Disease|| ||JH |
| | | | | |
| | | | | |
| |- | | |- |
− | |Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH | + | | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH |
| | | | | |
| | | | | |
| |- | | |- |
− | |Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH | + | | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH |
| | | | | |
| | | | | |
| |- | | |- |
− | |Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease|| ||JH | + | | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease|| ||JH |
| | | | | |
| | | | | |
| |- | | |- |
− | |Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease|| ||JH | + | | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease|| ||JH |
| | | | | |
| | | | | |
| |- | | |- |
− | |??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH | + | | ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH |
| | | | | |
| | | | | |
| |- | | |- |
− | |??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH | + | | ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH |
| | | | | |
| | | | | |
Line 340: |
Line 340: |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | |B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| ||YA | + | | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| ||YA |
| | | | | |
| | | | | |
Line 460: |
Line 460: |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Plasma Cell Neoplasms||'''''Overview'''''|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Plasma Cell Myeloma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Plasma Cell Myeloma Variants||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Plasmacytoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Monoclonal Immunoglobulin Deposition Diseases||'''''Overview'''''|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Primary Amyloidosis||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Light Chain and Heavy Chain Deposition Disease||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome||'''''Overview'''''|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | POEMS Syndrome||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | TEMPI Syndrome||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Nodal Marginal Zone Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Paediatric Nodal Marginal Zone Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Follicular Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Testicular Follicular Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | In Situ Follicular Neoplasia||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Duodenal-Type Follicular Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Paediatric-Type Follicular Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Mantle Cell Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | In Situ Mantle Cell Neoplasia||Disease|| ||SP |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | | || || || |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Example||Example|| ||Greg Corboy (GC) |
| | | | | |
| | | | | |
| |- | | |- |
− | |Example||Example|| ||Example | + | |Example||Example|| ||GC |
| | | | | |
| | | | | |